Eris Biotech

Our drugs engage the immune system to fight tumors

Healthcare Biotech Therapeutics Drug discovery Oncologyローンチ 2024年1月26日

Eris Biotech とは？

We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma.

まだコメントはありません。最初のひとりになりましょう！